Based on the above, it was speculated that inhibiting the expression of DNMT1 could suppress the IGFBP2/EGFR/STAT3/PD-L1 pathway, thereby inhibiting the progression of PCa. The gene discussed is IGFBP2; the disease is posterior cortical atrophy.